Call Now: +1 858 800 3101 Email: info@innopep.com
| Overview | |
|---|---|
| Description | CHRG01 is derived from human ?-defensin 3 (hBD3) C-terminal amino acids 54 to 67, with all Cys residues substituted with Ser. This substitution removes all disulfide bond linkages within the sequence. CHRG01, like hBD3, displays electrostatic-dependent antimicrobial properties. |
| Sequence | KSSTRGRKSSRRKK |
| Sequence (3 Letter) | H - Lys - Ser - Ser - Thr - Arg - Gly - Arg - Lys - Ser - Ser - Arg - Arg - Lys - Lys - OH |
| Molecular Weight | 1661.9 |
| Properties | |
| Purity | % Peak Area By HPLC ≥ 95% |
| Storage | -20 °C |
InnoPep Inc. is a company started by a couple of researchers with decades of expertise in peptide synthesis and conjugation aimed at enabling.